Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank80
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-153.26%
↑ 68% vs avg
Percentile
P80
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-485.81%
Historical baseline
PeriodValueYoY Change
TTM-153.26%+93.7%
2024-2425.82%-30.7%
2023-1855.76%-102.1%
2022-918.06%-133.2%
20212764.45%+946.9%
2020-326.41%-